Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA) ...

Pending FDA feedback, the Company will also seek FDA orphan drug designation (“ODD”) and NDA marketing approval for the XRx-026 program. Previously, oxypurinol was granted ODD for allopurinol ...

The new drug development program - XRx-026 - will focus on the treatment of individuals who have gout and are intolerant to allopurinol. With the clinical development of XORLOTM 1 having advanced ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When ...

Allopurinol (Lopurin ... to lower or minimize uric acid is to follow your gout treatment plan. Take the gout medication prescribed by your doctor as soon as you notice the first gout symptoms.

Dr Hilary Jones has said that the prevalence of gout is set to increase up to 70 per cent in the coming years - and ...

current drugs like allopurinol and febuxostat aren’t able to achieve that objective, and there are estimated to be around 160,000 people facing with refractory gout in the US. If approved ...